Adhesion of tumour-infiltrating lymphocytes to endothelium: A phenotypic and functional analysis

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1421-1431

  Adams, D H ^a,b   Yannelli, J R ^b   Newman, W ^c   Lawley, T ^d   Ades, E ^e   Rosenberg, S A ^b   Shaw, S ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Endothelium; Melanoma; Tumour infiltrating lymphocytes

Indexed keywords

CD30 ANTIGEN; CD31 ANTIGEN; CD69 ANTIGEN; INTEGRIN; LYMPHOCYTE ANTIGEN;

ARTICLE; CELL ADHESION; CELL SURFACE; CLINICAL ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MELANOMA; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0031002880     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.245     Document Type: Article

References (71)

1. Adams DH (1996) Lymphocyte-endothelial interactions in hepatic inflammation. Hepatogastroenterology 43: 32-43
2. Adams DH and Shaw S (1994) Leucocyte endothelial interactions and regulation of leucocyte migration. Lancet 343: 831-836
3. Adams DH and Nash GB (1996) Disturbance of leukocyte circulation and adhesion to endothelium as factors in circulatory pathology. Br J Anaesth 77: 17-31
4. Adams DH, Burra P, Hubscher SG, Elias E and Newman W (1994) Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 19: 588-594
5. Adams DH, Williams A, Hubscher SG and Robinson M (1990) Expression of E-selectin (CD62E) and E-selectin ligands in human liver inflammation. Hepatology 24: 533-538
6. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC and Lawley TJ (1993) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690
7. Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J and Rosenberg SA (1991) Lysis of autologus tumor cells by tumor-infiltrating lymphocytes correlates with clinical response in patients with malignant melanoma. J Natl Cancer Inst 83: 932-937
8. Ardman B, Sikorski MA and Staunton DE (1992) CD43 interferes with T-lymphocyte adhesion. Proc Natl Acad Sci USA 89: 5001-5005
9. Aruffo A, Stamenkovic I, Melnick M, Underhill CB and Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303- 1313
10. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK, Picker LJ and Butcher EC (1991) The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 174: 1461-1466
11. Butcher EC (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036
12. Butcher EC and Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272: 60-66
13. Clayberger C, Krensky AM, McIntyre BW, Koller TD, Parham P, Brodsky F, Linn DJ and Evans EL (1987) Identification and characterization of two novel lymphocyte function-associated antigens, L24 and L25. J Immunol 138: 1510-1514
14. Crabtree GR (1989) Contingent genetic regulatory events in T lymphocyte activation. Science 243: 355-361
15. Dunkley M, Pabst R and Cripps A (1995) An important role for intestinally derived T cells in respiratory defense. Immunol Today 16: 231-236
16. Faustman D, Lacy P, Davie J and Hauptfeld V (1982)Prevention of allograft rejection by immunization with donor blood depleted of Ia-bearing cells. Science 217: 157-158
17. Fisher LL and Ottaway CA (1990) The kinetics of migration of murine CD4 and CD8 lymphocytes in vivo. Reg Immunol 3: 156-162
18. Graber N, Gopal TV, Wilson D, Beall LD, Polte T and Newman W (1990) T-cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and ELAM-1. J Immunol 145: 819-830
19. Griffith KD, Read EJ, Carrasquillo JA, Carter CS, Yang JC, Fisher B, Aebersold P, Packard BS, Yu MY and Rosenberg SA (1989) In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 81: 1709-1717
20. Hildreth JE, Gotch FM, Hildreth PD and McMichael AJ (1983) A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol 13: 202-208
21. Horgan KJ and Shaw S (1991) Immunomagnetic purification of T cell subpopulations. Section 7.4. In Current Protocols in Immunology, Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W. (eds), pp. 7.4.1-7.4.5. Wiley Interscience: New York
22. Horgan KJ, Van Seventer GA, Shimizu Y and Shaw S (1990) Hyporesponsiveness of naive (CD45RA+) human T cells to multiple receptor-mediated stimuli but augmentation of responses by costimuli. Eur J Immunol 20: 1111-1118
23. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11-25
24. Itoh K, Tilden AB and Balch CM (1986) Interleukin-2 activation of cytotoxic T lymphocytes infiltrating into human metastatic melanomas. Cancer Res 46: 3011-3017
25. Jalkanen S, Bargatze RF, De Los Toyos J and Butcher EC (1987) Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105: 983-990
26. Lazarovits AI, Moscicki RA, Kurnick JT, Camerini D, Bhan AK, Baird LG, Erikson M and Colvin RB (1984) Lymphocyte activation antigens. I. A monoclonal antibody, Act-I, defines a new late lymphocyte activation antigen. J Immunol 133: 1857-1862
27. Lopez-Cabera M, Santis AG, Fernandez-Ruiz E, Blacher R, Esch F, Sanchez-Mateos P and Sanchez-Madrid F (1993) Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member or the C-type animal lectin superfamily of signal transmitting receptors. J Exp Med
28. Makgoba MW, Sanders ME, Luce GEG, Dustin ML, Springer TA, Clark EA, Mannoni P and Shaw S (1988) ICAM-1 a ligand for LHA-1 dependent adhesion of B, T and myeloid cells. Nature 331: 86-88
29. Manjunath N, Johnson RS, Staunton DE, Pasqualini R and Ardman B (1993) Targeted disruption of CD43 gene enhances T lymphocyte adhesion. J Immunol 151: 1528-1534
30. Matsuyama T, Yamada A, Kay J, Yamada KM, Akiyama SK, Schlossman SF and Morimoto C (1989) Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med 170: 1133-1148
31. Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, Augugliaro R, Bottino C, Ciccone E and Moretta L (1991) CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor a/b. J Exp Med 174: 1393-1398
32. Nakamura S, Sung S-SJ, Bjorndahl JM and Hu SM (1989) Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA1. J Exp Med 169: 677-689
33. Picker LJ and Butcher EC (1992) Physiologic and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 10: 561
34. Picker LJ, Michie SA, Rott LS and Butcher EC (1990a) A unique phenotype of skin-associated lymphocytes in humans preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 136: 1053-1068
35. Picker LJ, Terstappen LWMM, Rott LS, Streeter PR, Stein H and Butcher EC (1990b) Differential expression of homing-associated adhesion molecules by T cell subsets in man. J Immunol 145: 3247-3255
36. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR and Terstappen LW (1993a) Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1500: 1122-1136
37. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D and Terstappen LW (1993b) Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol 150: 1105-1121
38. Pockaj BA, Sherry R, Wei J, Yannelli JR, Carter CS, Leitman SK Carrasquillo JR, White DE, Steinberg SM, Rosenberg SA and Yang JC (1994) Localisation of Indium-labelled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy: augmentation with cyclophosphamide and association with response. Cancer 73: 1731-1737
39. Poppema S, Brocker EB, De Leij L, Terbrack D, Visscher T, Ter Haar A, Macher E, The TH and Sorg C (1983) In situ analysis of the mononuclear cell infiltrate of primary malignant melanoma in the skin. Clin Exp Immunol 51: 77-82
40. Ravaud A, Legrand E, Delaunay MM, Bussieres E, Coulon V, Cany L, Huet S, Verdier D, Kind M, Chomy F, Bui BN and Gualde N (1995) A phase I trial of repeated tumor-infiltrating lymphocyte (TIL) infusion in metastatic melanoma. Br J Cancer 71: 331-336
41. Rice GE, Munro JM, Corless C and Bevilacqua MP (1991) Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 138: 385-393
42. Rohde D, Schluter-Wigger W, Mielke V, Von Denriesch P, Von Gaudecker B and Sterry W (1992) Infiltration of both T cells and neutrophils in the skin is accompanied by the expression of endothelial leukocyte adhesion molecule-1 (ELAM-1): an immunohistochemical and ultrastructural study. J Invest Dermatol 98: 794-799
43. Rosenberg SA, Spiess P and Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes. Science 233: 1318-1321
44. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Young JC, Seipp CA, Simpson C, Carter C, Bock S, Swartzentruber D, Wei JP and White DE (1988) Special report: use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 319: 1676-1680
45. Salmi M, Granfors K, Leirisalo-Repo M, Hamalainen M, MacDermott R, Leino R, Havia T and Jalkanen S (1992) Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci USA 89: 11436-11440
46. Salmi M, Grenman R, Grenman S, Nordman E and Jalkanen S (1995) Tumor endothelium selectively supports binding of IL-2-propagated tumor-infiltrating lymphocytes. J Immunol 154: 6002-6012
47. Schieferdecker HL, Ullrich R, Weiss-Breckwoldt AN, Schwarting R, Stein H, Riecken E-O and Zeitz M (1990) The HML-1 antigen of intestinal lymphocytes is an activation antigen. J Immunol 144: 2541-2549
48. Schmitt-Verhulst A (1994) Molecular basis of Immunity 1994: summary of sessions at the 1994 HNII Conference. Res Immunol 145: 297-314
49. Schweighoffer T, Tanaka Y, Tidswell M, Erle DJ, Horgan KJ, Luce GE, Lazarovitz AI, Buck D and Shaw S (1993) Selective expression of integrin a4b7 on a subset of human CD4+ memory T cells with hallmarks of gut-trophism. J Immunol 151: 717-729
50. Shaw S, Luce GEG and Gilks WR (1994) Leucocyte differentiation antigen database. In Leucocyte Typing, V, Schlossman SF, Boumsell L, Gilks WR, Harlan JM, Kishimoto T, Morimoto, Ritz J, Shaw S, Silverstein RL, Springer TA, Tedder TF and Todd RF (eds), pp. 1172-1182. Oxford University Press: Oxford
51. Shimizu Y, Van Seventer GA, Horgan KJ and Shaw S (1990a) Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 145: 59-67
52. Shimizu Y, Van Seventer GA, Horgan KJ and Shaw S (1990b) Roles of adhesion molecules in T cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol Rev 114: 109-143
53. Shimizu Y, Van Seventer GA, Horgan KJ and Shaw S (1990c) Regulated expression and function of three VLA (b1) integrin receptors on T cells. Nature 345, 250-253
54. Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, Van Seventer GA and Shaw S (1991a) Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1 and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 113: 1203-1212
55. Shimizu Y, Shaw S, Graber N, Gopal TV, Horgan KJ, Van Seventer GA and Newman W (1991b) Activation-independent binding of human memory T cells to ELAM-1. Nature 349: 799-802
56. Shimizu Y, Newman W, Tanaka Y and Shaw S (1992) Lymphocyte interactions with endothelial cells. Immunol Today 13: 106-112
57. Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA Jr and Tedder TF (1991) Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 147: 2565-2573
58. Spiess P, Yang J and Rosenberg SA (1987) In vivo antitumor activity of tumor infiltrating lymphocytes expanded in recombinant interleukin-2. J Natl Cancer Inst 79: 1067-1075
59. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314
60. Swerlick RA, Lee KH, Li L, Sepp NT, Caughman SW and Lawley TJ (1992) Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 149: 698-705
61. Takada Y, Elices MJ, Crouse C and Hemler ME (1989) The primary structure of the alpha-4 subunit of VLA-4 - homology to other integrins and a possible cell-cell adhesion function. EMBO J 8: 1361-1368
62. Tanaka Y, Albelda SM, Horgan KJ, Van Seventer GA, Shimizu Y, Newman W, Hallam J, Newman PJ, Buck CA and Shaw S (1992) CD31 expressed on distinctive T cell subsets is a preferential amplifier of b1 integrin-mediated adhesion. J Exp Med 176: 245-253
63. Tanaka Y, Adams DH, Hubscher S, Hirano H, Siebenlist U and Shaw S (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature 361: 79-82
64. Tugores A, Alonso MA, Sanchez-Madrid F and De Landazuri MO (1992) Human T cell activation through the activation-inducer molecule CD69 enhances the activity of transcription factor AP-1. J Immunol 148: 2300-2307
65. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van Den Eynde B, Knuth A and Boon T (1991) A gene encoding an antigen recognised by cytolytic T lymphocytes on a human melanoma. Science 2: 1643-1647
66. Van Seventer GA, Shimizu Y, Horgan KJ and Shaw S (1990) The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 144: 4579-4586
67. Whiteside TL and Herberman RB (1992) Extravasation of antitumor effector cells. Invasion Metastasis 12: 128-146
68. Xu DS, Sorrell MF, Clemens DL, Casey CA and Tuma DJ (1994) Effects of ethanol feeding on the interaction of rat hepatocytes with laminin peptides. Alcoholism - Clinical and Experimental Research 18: 1215-1219
69. Yannelli JR (1991) The preparation of effector cells for use in the adoptive cellular therapy of cancer. J Immunol Methods 139: 1-16
70. Yoong KF and Adams DH (1996) Tumour infiltrating lymphocytes: insights into tumour immunology and potential for immunotherapy. J Clin Molec Pathol (in press)
71. Yoong KF, Williams A, Hubscher SG, Salmi M, Jalkanen S and Adams DH (1996) Expression of endothelial adhesion molecules and T-cell homing receptors in human hepatic-tumors. FASEB J 10: 2473